158 related articles for article (PubMed ID: 25987077)
1. Expression of RECK and MMPs in Hepatoblastoma and Neuroblastoma and Comparative Analysis on the Tumor Metastasis.
Xu M; Wang HF; Zhang HZ
Asian Pac J Cancer Prev; 2015; 16(9):4007-11. PubMed ID: 25987077
[TBL] [Abstract][Full Text] [Related]
2. Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis.
Dong Q; Yu D; Yang CM; Jiang B; Zhang H
Int J Exp Pathol; 2010 Aug; 91(4):368-73. PubMed ID: 20579139
[TBL] [Abstract][Full Text] [Related]
3. [Expression of MT1-MMP and RECK protein in human gastric carcinoma].
Shen B; Zheng MQ; Xu XY; Mo FG; Zhang T; Feng JF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):364-7. PubMed ID: 22338226
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
Liu N; Zhou B; Zhu G
Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
[TBL] [Abstract][Full Text] [Related]
5. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
6. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.
Wang L; Wang Q; Li HL; Han LY
Asian Pac J Cancer Prev; 2013; 14(3):2113-8. PubMed ID: 23679328
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
[TBL] [Abstract][Full Text] [Related]
8. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
9. Spatial analysis of RECK, MT1-MMP, and TIMP-2 proteins during early Xenopus laevis development.
Willson JA; Damjanovski S
Gene Expr Patterns; 2019 Dec; 34():119066. PubMed ID: 31352120
[TBL] [Abstract][Full Text] [Related]
10. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
Xin C; Buhe B; Hongting L; Chuanmin Y; Xiwei H; Hong Z; Lulu H; Qian D; Renjie W
FEBS J; 2013 Feb; 280(3):855-66. PubMed ID: 23176145
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated energy homeostasis: hepatoblastoma and neuroblastoma affect glucose and lipid metabolism as well as ghrelin, GLP-1, and PYY in nude rats.
Till H; Schlichting N; Oberbach A
Eur J Pediatr Surg; 2015 Feb; 25(1):128-31. PubMed ID: 25111274
[TBL] [Abstract][Full Text] [Related]
13. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
14. [Expression of RECK, RAGE and MMP-9 in nasopharyngeal carcinoma and its significance].
Li R; Deng Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 24(18):823-7. PubMed ID: 21254649
[TBL] [Abstract][Full Text] [Related]
15. RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling.
Noda M; Oh J; Takahashi R; Kondo S; Kitayama H; Takahashi C
Cancer Metastasis Rev; 2003; 22(2-3):167-75. PubMed ID: 12784995
[TBL] [Abstract][Full Text] [Related]
16. Reversion-inducing cysteine-rich protein with Kazal motifs and MT1-MMP promote the formation of robust fibrillin fibers.
Matsuzaki T; Keene DR; Nishimoto E; Noda M
J Cell Physiol; 2021 Mar; 236(3):1980-1995. PubMed ID: 32730638
[TBL] [Abstract][Full Text] [Related]
17. Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression.
Nyalendo C; Sartelet H; Barrette S; Ohta S; Gingras D; Béliveau R
BMC Cancer; 2009 Dec; 9():422. PubMed ID: 19961596
[TBL] [Abstract][Full Text] [Related]
18. The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways.
Miki T; Takegami Y; Okawa K; Muraguchi T; Noda M; Takahashi C
J Biol Chem; 2007 Apr; 282(16):12341-52. PubMed ID: 17329256
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
20. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
